Drug Retention Rate and Causes of Discontinuation of Adalimumab in Uveitis: Real-World Data from the Biotherapies in Uveitis (BioÚvea) Study Group.
Llorenç V, Cordero-Coma M, Blanco-Esteban A, Heras-Mulero H, Losada-Castillo MJ, Jovani-Casano V, Valls-Pascual E, Jodar-Marquez M, García-Aparicio Á, Fonollosa A, González-Guijarro JJ, Rodriguez-Melian L, Fernández-Prada M, Jerez-Fidalgo M, Hernandez-Garfella M, Esquinas C, Sainz-de-la-Maza M, Adán A; Biotherapies in Uveitis (BioÚvea) Study Group.
Llorenç V, et al. Among authors: heras mulero h.
Ophthalmology. 2020 Jun;127(6):814-825. doi: 10.1016/j.ophtha.2019.11.024. Epub 2019 Dec 2.
Ophthalmology. 2020.
PMID: 31952883
Free article.